MENU
+Compare
VNRX
Stock ticker: ASE
AS OF
Oct 8, 03:33 PM (EDT)
Price
$0.64
Change
-$0.01 (-1.54%)
Capitalization
69.94M

VNRX VolitionRX Limited Forecast, Technical & Fundamental Analysis

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19... Show more

VNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VNRX with price predictions
Oct 07, 2025

Momentum Indicator for VNRX turns positive, indicating new upward trend

VNRX saw its Momentum Indicator move above the 0 level on October 06, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 99 similar instances where the indicator turned positive. In of the 99 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 69 cases where VNRX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VNRX just turned positive on September 30, 2025. Looking at past instances where VNRX's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

VNRX moved above its 50-day moving average on October 07, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VNRX advanced for three days, in of 228 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 72 cases where VNRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VNRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VNRX broke above its upper Bollinger Band on September 19, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VNRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (60.705). P/E Ratio (0.000) is within average values for comparable stocks, (37.576). VNRX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.695). VNRX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (46.948) is also within normal values, averaging (81.508).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VNRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
VNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VNRX is expected to report earnings to fall 37.50% to -3 cents per share on November 13

VolitionRX Limited VNRX Stock Earnings Reports
Q3'25
Est.
$-0.04
Q2'25
Missed
by $0.01
Q1'25
Missed
by $0.02
Q4'24
Est.
$-0.05
Q3'24
Est.
$-0.07
The last earnings report on August 15 showed earnings per share of -5 cents, missing the estimate of -4 cents. With 80.02K shares outstanding, the current market capitalization sits at 69.94M.
A.I. Advisor
published General Information

General Information

a development stage life sciences company

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
1489 West Warm Springs Road
Phone
+1 646 650-1351
Employees
110
Web
https://www.volition.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INPAP80.00N/A
N/A
International Paper Company
JWCTF0.53N/A
N/A
JW CAYMAN THERAPEUTICS CO LTD.
SEPLF2.36N/A
N/A
SEPLAT ENERGY PLC.
OFSTF0.49N/A
-0.70%
Carbon Streaming Corporation
UNCHF6.50-0.05
-0.76%
Unicharm Corp.

VNRX and Stocks

Correlation & Price change

A.I.dvisor tells us that VNRX and STRRP have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VNRX and STRRP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNRX
1D Price
Change %
VNRX100%
+0.81%
STRRP - VNRX
27%
Poorly correlated
N/A
TLSI - VNRX
27%
Poorly correlated
+3.24%
SRDX - VNRX
25%
Poorly correlated
+0.42%
VAPO - VNRX
25%
Poorly correlated
N/A
IMDX - VNRX
24%
Poorly correlated
+12.20%
More

Groups containing VNRX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNRX
1D Price
Change %
VNRX100%
+0.81%
Health Services
category (432 stocks)
8%
Poorly correlated
+0.91%
Medical/Nursing Services
category (222 stocks)
5%
Poorly correlated
+1.29%